Mark E. Mcgovern

Mark E. Mcgovern is a declared insider at 2 companies (board member); the most frequent names are KOS Pharmaceuticals Inc and Esperion Therapeutics, Inc. Between 26 January 2006 and 27 May 2021, the trades on record add up to 11 filings.

The open-market side counts 2 purchases for €45k alongside 2 sales for €1.2M. The net balance comes to €1.1M on the selling side. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 4 share grants and 2 option exercises.

Most recently, on 28 May 2021, the filings show a share grant in Esperion Therapeutics, Inc. The most recent open-market purchase was published on 7 July 2016, 3,761 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.